| J9271 | Injection, pembrolizumab, 1 mg | 9,400 | $40 | $404.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 830 | $110 | $87.5K |
| J0897 | Injection, denosumab, 1 mg | 4,200 | $20 | $75.6K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 55,500 | $1 | $55.5K |
| Q5111 | Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg | 370 | $110 | $39.8K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 220 | $120 | $26.4K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 2,500 | $10 | $15K |
| 99223 | The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 90 | $150 | $12.7K |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 1,580 | $10 | $9.5K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 70 | $130 | $9.2K |